 | • レポートコード：MRC2Q12-16727 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療 |
| Single User | ￥735,000 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,470,000 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、喘息アレルギー治療のグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 喘息アレルギー治療のアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 喘息アレルギー治療の中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 喘息アレルギー治療のヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までの喘息アレルギー治療の生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別の喘息アレルギー治療の売上および2028年までの予測に焦点を当てています。 喘息アレルギー治療のグローバル主要企業には、Johnson & Johnson、Allergopharma、Sanofi SA、McNeil Consumer Healthcare、Genentech、GlaxoSmithKline PLC、Leti Pharma、Alerpharma、Allergan、Meda Pharmaceuticals、Novartis International、Bausch Health Companiesなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 喘息アレルギー治療市場は、タイプとアプリケーションによって区分されます。世界の喘息アレルギー治療市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 抗アレルギー薬、免疫療法 【アプリケーション別セグメント】 病院薬局、小売店薬局、オンライン薬局、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 喘息アレルギー治療製品概要 - タイプ別市場（抗アレルギー薬、免疫療法） - アプリケーション別市場（病院薬局、小売店薬局、オンライン薬局、その他） - 調査の目的 ・エグゼクティブサマリー - 世界の喘息アレルギー治療販売量予測2017-2028 - 世界の喘息アレルギー治療売上予測2017-2028 - 喘息アレルギー治療の地域別販売量 - 喘息アレルギー治療の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別喘息アレルギー治療販売量 - 主要メーカー別喘息アレルギー治療売上 - 主要メーカー別喘息アレルギー治療価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（抗アレルギー薬、免疫療法） - 喘息アレルギー治療のタイプ別販売量 - 喘息アレルギー治療のタイプ別売上 - 喘息アレルギー治療のタイプ別価格 ・アプリケーション別市場規模（病院薬局、小売店薬局、オンライン薬局、その他） - 喘息アレルギー治療のアプリケーション別販売量 - 喘息アレルギー治療のアプリケーション別売上 - 喘息アレルギー治療のアプリケーション別価格 ・北米市場 - 北米の喘息アレルギー治療市場規模（タイプ別、アプリケーション別） - 主要国別の喘息アレルギー治療市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの喘息アレルギー治療市場規模（タイプ別、アプリケーション別） - 主要国別の喘息アレルギー治療市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の喘息アレルギー治療市場規模（タイプ別、アプリケーション別） - 主要国別の喘息アレルギー治療市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の喘息アレルギー治療市場規模（タイプ別、アプリケーション別） - 主要国別の喘息アレルギー治療市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの喘息アレルギー治療市場規模（タイプ別、アプリケーション別） - 主要国別の喘息アレルギー治療市場規模（トルコ、サウジアラビア） ・企業情報 Johnson & Johnson、Allergopharma、Sanofi SA、McNeil Consumer Healthcare、Genentech、GlaxoSmithKline PLC、Leti Pharma、Alerpharma、Allergan、Meda Pharmaceuticals、Novartis International、Bausch Health Companies ・産業チェーン及び販売チャネル分析 - 喘息アレルギー治療の産業チェーン分析 - 喘息アレルギー治療の原材料 - 喘息アレルギー治療の生産プロセス - 喘息アレルギー治療の販売及びマーケティング - 喘息アレルギー治療の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 喘息アレルギー治療の産業動向 - 喘息アレルギー治療のマーケットドライバー - 喘息アレルギー治療の課題 - 喘息アレルギー治療の阻害要因 ・主な調査結果 |
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Asthma Allergy Treatment estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Asthma Allergy Treatment is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Asthma Allergy Treatment is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Asthma Allergy Treatment is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key companies of Asthma Allergy Treatment include Johnson & Johnson, Allergopharma, Sanofi SA, McNeil Consumer Healthcare, Genentech, GlaxoSmithKline PLC, Leti Pharma, Alerpharma and Allergan, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, revenue and gross margin. Major players’ headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Asthma Allergy Treatment companies, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Asthma Allergy Treatment market. Further, it explains the major drivers and regional dynamics of the global Asthma Allergy Treatment market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Johnson & Johnson
Allergopharma
Sanofi SA
McNeil Consumer Healthcare
Genentech
GlaxoSmithKline PLC
Leti Pharma
Alerpharma
Allergan
Meda Pharmaceuticals
Novartis International
Bausch Health Companies
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.
Asthma Allergy Treatment Segment by Type
Anti-allergy Drugs
Immunotherapy
Asthma Allergy Treatment Segment by Application
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Others
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Asthma Allergy Treatment market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Asthma Allergy Treatment market size. Analyses of the global market trends, with historic market revenue data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Asthma Allergy Treatment, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Asthma Allergy Treatment, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Asthma Allergy Treatment revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Asthma Allergy Treatment market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Asthma Allergy Treatment revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Johnson & Johnson, Allergopharma, Sanofi SA, McNeil Consumer Healthcare, Genentech, GlaxoSmithKline PLC, Leti Pharma, Alerpharma and Allergan, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Asthma Allergy Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Asthma Allergy Treatment companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country/region, revenue for each segment.
Chapter 9: Latin America by type, by application and by country, revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Asthma Allergy Treatment revenue, gross margin, and recent development, etc.
Chapter 12: Analyst’s Viewpoints/Conclusions
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Asthma Allergy Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Anti-allergy Drugs
1.2.3 Immunotherapy
1.3 Market by Application
1.3.1 Global Asthma Allergy Treatment Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Asthma Allergy Treatment Market Perspective (2017-2028)
2.2 Asthma Allergy Treatment Growth Trends by Region
2.2.1 Asthma Allergy Treatment Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Asthma Allergy Treatment Historic Market Size by Region (2017-2022)
2.2.3 Asthma Allergy Treatment Forecasted Market Size by Region (2023-2028)
2.3 Asthma Allergy Treatment Market Dynamics
2.3.1 Asthma Allergy Treatment Industry Trends
2.3.2 Asthma Allergy Treatment Market Drivers
2.3.3 Asthma Allergy Treatment Market Challenges
2.3.4 Asthma Allergy Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Asthma Allergy Treatment Players by Revenue
3.1.1 Global Top Asthma Allergy Treatment Players by Revenue (2017-2022)
3.1.2 Global Asthma Allergy Treatment Revenue Market Share by Players (2017-2022)
3.2 Global Asthma Allergy Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Asthma Allergy Treatment Revenue
3.4 Global Asthma Allergy Treatment Market Concentration Ratio
3.4.1 Global Asthma Allergy Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Asthma Allergy Treatment Revenue in 2021
3.5 Asthma Allergy Treatment Key Players Head office and Area Served
3.6 Key Players Asthma Allergy Treatment Product Solution and Service
3.7 Date of Enter into Asthma Allergy Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Asthma Allergy Treatment Breakdown Data by Type
4.1 Global Asthma Allergy Treatment Historic Market Size by Type (2017-2022)
4.2 Global Asthma Allergy Treatment Forecasted Market Size by Type (2023-2028)
5 Asthma Allergy Treatment Breakdown Data by Application
5.1 Global Asthma Allergy Treatment Historic Market Size by Application (2017-2022)
5.2 Global Asthma Allergy Treatment Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Asthma Allergy Treatment Market Size (2017-2028)
6.2 North America Asthma Allergy Treatment Market Size by Type
6.2.1 North America Asthma Allergy Treatment Market Size by Type (2017-2022)
6.2.2 North America Asthma Allergy Treatment Market Size by Type (2023-2028)
6.2.3 North America Asthma Allergy Treatment Market Share by Type (2017-2028)
6.3 North America Asthma Allergy Treatment Market Size by Application
6.3.1 North America Asthma Allergy Treatment Market Size by Application (2017-2022)
6.3.2 North America Asthma Allergy Treatment Market Size by Application (2023-2028)
6.3.3 North America Asthma Allergy Treatment Market Share by Application (2017-2028)
6.4 North America Asthma Allergy Treatment Market Size by Country
6.4.1 North America Asthma Allergy Treatment Market Size by Country (2017-2022)
6.4.2 North America Asthma Allergy Treatment Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Asthma Allergy Treatment Market Size (2017-2028)
7.2 Europe Asthma Allergy Treatment Market Size by Type
7.2.1 Europe Asthma Allergy Treatment Market Size by Type (2017-2022)
7.2.2 Europe Asthma Allergy Treatment Market Size by Type (2023-2028)
7.2.3 Europe Asthma Allergy Treatment Market Share by Type (2017-2028)
7.3 Europe Asthma Allergy Treatment Market Size by Application
7.3.1 Europe Asthma Allergy Treatment Market Size by Application (2017-2022)
7.3.2 Europe Asthma Allergy Treatment Market Size by Application (2023-2028)
7.3.3 Europe Asthma Allergy Treatment Market Share by Application (2017-2028)
7.4 Europe Asthma Allergy Treatment Market Size by Country
7.4.1 Europe Asthma Allergy Treatment Market Size by Country (2017-2022)
7.4.2 Europe Asthma Allergy Treatment Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Asthma Allergy Treatment Market Size (2017-2028)
8.2 Asia-Pacific Asthma Allergy Treatment Market Size by Type
8.2.1 Asia-Pacific Asthma Allergy Treatment Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Asthma Allergy Treatment Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Asthma Allergy Treatment Market Share by Type (2017-2028)
8.3 Asia-Pacific Asthma Allergy Treatment Market Size by Application
8.3.1 Asia-Pacific Asthma Allergy Treatment Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Asthma Allergy Treatment Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Asthma Allergy Treatment Market Share by Application (2017-2028)
8.4 Asia-Pacific Asthma Allergy Treatment Market Size by Region
8.4.1 Asia-Pacific Asthma Allergy Treatment Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Asthma Allergy Treatment Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Asthma Allergy Treatment Market Size (2017-2028)
9.2 Latin America Asthma Allergy Treatment Market Size by Type
9.2.1 Latin America Asthma Allergy Treatment Market Size by Type (2017-2022)
9.2.2 Latin America Asthma Allergy Treatment Market Size by Type (2023-2028)
9.2.3 Latin America Asthma Allergy Treatment Market Share by Type (2017-2028)
9.3 Latin America Asthma Allergy Treatment Market Size by Application
9.3.1 Latin America Asthma Allergy Treatment Market Size by Application (2017-2022)
9.3.2 Latin America Asthma Allergy Treatment Market Size by Application (2023-2028)
9.3.3 Latin America Asthma Allergy Treatment Market Share by Application (2017-2028)
9.4 Latin America Asthma Allergy Treatment Market Size by Country
9.4.1 Latin America Asthma Allergy Treatment Market Size by Country (2017-2022)
9.4.2 Latin America Asthma Allergy Treatment Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Asthma Allergy Treatment Market Size (2017-2028)
10.2 Middle East & Africa Asthma Allergy Treatment Market Size by Type
10.2.1 Middle East & Africa Asthma Allergy Treatment Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Asthma Allergy Treatment Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Asthma Allergy Treatment Market Share by Type (2017-2028)
10.3 Middle East & Africa Asthma Allergy Treatment Market Size by Application
10.3.1 Middle East & Africa Asthma Allergy Treatment Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Asthma Allergy Treatment Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Asthma Allergy Treatment Market Share by Application (2017-2028)
10.4 Middle East & Africa Asthma Allergy Treatment Market Size by Country
10.4.1 Middle East & Africa Asthma Allergy Treatment Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Asthma Allergy Treatment Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Company Details
11.1.2 Johnson & Johnson Business Overview
11.1.3 Johnson & Johnson Asthma Allergy Treatment Introduction
11.1.4 Johnson & Johnson Revenue in Asthma Allergy Treatment Business (2017-2022)
11.1.5 Johnson & Johnson Recent Developments
11.2 Allergopharma
11.2.1 Allergopharma Company Details
11.2.2 Allergopharma Business Overview
11.2.3 Allergopharma Asthma Allergy Treatment Introduction
11.2.4 Allergopharma Revenue in Asthma Allergy Treatment Business (2017-2022)
11.2.5 Allergopharma Recent Developments
11.3 Sanofi SA
11.3.1 Sanofi SA Company Details
11.3.2 Sanofi SA Business Overview
11.3.3 Sanofi SA Asthma Allergy Treatment Introduction
11.3.4 Sanofi SA Revenue in Asthma Allergy Treatment Business (2017-2022)
11.3.5 Sanofi SA Recent Developments
11.4 McNeil Consumer Healthcare
11.4.1 McNeil Consumer Healthcare Company Details
11.4.2 McNeil Consumer Healthcare Business Overview
11.4.3 McNeil Consumer Healthcare Asthma Allergy Treatment Introduction
11.4.4 McNeil Consumer Healthcare Revenue in Asthma Allergy Treatment Business (2017-2022)
11.4.5 McNeil Consumer Healthcare Recent Developments
11.5 Genentech
11.5.1 Genentech Company Details
11.5.2 Genentech Business Overview
11.5.3 Genentech Asthma Allergy Treatment Introduction
11.5.4 Genentech Revenue in Asthma Allergy Treatment Business (2017-2022)
11.5.5 Genentech Recent Developments
11.6 GlaxoSmithKline PLC
11.6.1 GlaxoSmithKline PLC Company Details
11.6.2 GlaxoSmithKline PLC Business Overview
11.6.3 GlaxoSmithKline PLC Asthma Allergy Treatment Introduction
11.6.4 GlaxoSmithKline PLC Revenue in Asthma Allergy Treatment Business (2017-2022)
11.6.5 GlaxoSmithKline PLC Recent Developments
11.7 Leti Pharma
11.7.1 Leti Pharma Company Details
11.7.2 Leti Pharma Business Overview
11.7.3 Leti Pharma Asthma Allergy Treatment Introduction
11.7.4 Leti Pharma Revenue in Asthma Allergy Treatment Business (2017-2022)
11.7.5 Leti Pharma Recent Developments
11.8 Alerpharma
11.8.1 Alerpharma Company Details
11.8.2 Alerpharma Business Overview
11.8.3 Alerpharma Asthma Allergy Treatment Introduction
11.8.4 Alerpharma Revenue in Asthma Allergy Treatment Business (2017-2022)
11.8.5 Alerpharma Recent Developments
11.9 Allergan
11.9.1 Allergan Company Details
11.9.2 Allergan Business Overview
11.9.3 Allergan Asthma Allergy Treatment Introduction
11.9.4 Allergan Revenue in Asthma Allergy Treatment Business (2017-2022)
11.9.5 Allergan Recent Developments
11.10 Meda Pharmaceuticals
11.10.1 Meda Pharmaceuticals Company Details
11.10.2 Meda Pharmaceuticals Business Overview
11.10.3 Meda Pharmaceuticals Asthma Allergy Treatment Introduction
11.10.4 Meda Pharmaceuticals Revenue in Asthma Allergy Treatment Business (2017-2022)
11.10.5 Meda Pharmaceuticals Recent Developments
11.11 Novartis International
11.11.1 Novartis International Company Details
11.11.2 Novartis International Business Overview
11.11.3 Novartis International Asthma Allergy Treatment Introduction
11.11.4 Novartis International Revenue in Asthma Allergy Treatment Business (2017-2022)
11.11.5 Novartis International Recent Developments
11.12 Bausch Health Companies
11.12.1 Bausch Health Companies Company Details
11.12.2 Bausch Health Companies Business Overview
11.12.3 Bausch Health Companies Asthma Allergy Treatment Introduction
11.12.4 Bausch Health Companies Revenue in Asthma Allergy Treatment Business (2017-2022)
11.12.5 Bausch Health Companies Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer